Targeting Immune-Mediated Responses to Tackle GNE Myopathy †
Abstract
:1. Introduction
2. Materials and Methods
2.1. Standards and Reagents
2.2. Cell Culture
Cell Culture Treatments
2.3. Cell Viability
2.4. Cell Staining
2.5. Flow Cytometry
2.6. Statistical Analysis
3. Results and Discussion
3.1. Sialophenotype of GNEM-HEK cells
3.1.1. Sialic Acid Profile
3.1.2. MHC-I Signature
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Pogoryelova, O.; González Coraspe, J.A.; Nikolenko, N.; Lochmüller, H.; Roos, A. GNE myopathy: From clinics and genetics to pathology and research strategies. Orphanet J. Rare Dis. 2018, 13, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Böhm, S.; Schwab, I.; Lux, A.; Nimmerjahn, F. The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin. Immunopathol. 2012, 34, 443–453. [Google Scholar] [CrossRef] [PubMed]
- Krause, S.; Schlotter-Weigel, B.; Walter, M.C.; Najmabadi, H.; Wiendl, H.; Müller-Höcker, J.; Müller-Felber, W.; Pongratz, D.; Lochmüller, H. A novel homozygous missense mutation in the GNE gene of a patient with quadriceps-sparing hereditary inclusion body myopathy associated with muscle inflammation. Neuromuscul. Disord. 2003, 13, 830–834. [Google Scholar] [CrossRef]
- Silva, Z.; Ferro, T.; Almeida, D.; Soares, H.; Ferreira, J.A.; Deschepper, F.M.; Hensbergen, P.J.; Pirro, M.; van Vliet, S.J.; Springer, S.; et al. MHC Class I stability is modulated by cell surface sialylation in human dendritic cells. Pharmaceutics 2020, 12, 249. [Google Scholar] [CrossRef] [PubMed]
- Villanueva-Cabello, T.M.; Gutiérrez-Valenzuela, L.D.; Salinas-Marín, R.; López-Guerrero, D.V.; Martínez-Duncker, I. Polysialic acid in the immune system. Front. Immunol. 2022, 12. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Barbosa, M.; Pereira, B.L.; Videira, P.A. Targeting Immune-Mediated Responses to Tackle GNE Myopathy. Med. Sci. Forum 2022, 11, 9. https://doi.org/10.3390/BiTaP-12788
Barbosa M, Pereira BL, Videira PA. Targeting Immune-Mediated Responses to Tackle GNE Myopathy. Medical Sciences Forum. 2022; 11(1):9. https://doi.org/10.3390/BiTaP-12788
Chicago/Turabian StyleBarbosa, Mariana, Beatriz L. Pereira, and Paula A. Videira. 2022. "Targeting Immune-Mediated Responses to Tackle GNE Myopathy" Medical Sciences Forum 11, no. 1: 9. https://doi.org/10.3390/BiTaP-12788